-+ 0.00%
-+ 0.00%
-+ 0.00%

Azenta Q4 net income drops 87% year over year to $6.79 million

PUBT·11/10/2026 22:03:31
Azenta Q4 net income drops 87% year over year to $6.79 million
  • Azenta's fourth-quarter FY26 diluted EPS fell 86% year over year to $0.16.
  • Quarterly revenue rose 5% year over year to $167 million.
  • Full-year FY26 net loss more than doubled year over year to $166.99 million.
  • The business acquired synthetic biology company SynPlexity for a $15 million base cash purchase price to expand gene synthesis capabilities.
  • FY27 revenue is expected to reach $648 million to $660 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azenta Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611101630PR_NEWS_USPR_____NE94421) on November 10, 2026, and is solely responsible for the information contained therein.